Qiagen N.V. Statistics
NYSE: QGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
44.53-0.26 (-0.58%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Qiagen N.V. by the numbers
Qiagen N.V. has a market capitalization of $9.20 billion based on 206.50M shares outstanding. Its trailing P/E ratio is 22.6, below the 3-company peer median of 62.5, and its forward P/E is 17.0. The stock trades 2.7% above its 50-day average and 4.9% above its 200-day average.
Average daily trading volume is 2.58M shares, or about $114.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
QGEN valuation vs. peer median
| Metric | QGEN | Peer median | Difference |
|---|---|---|---|
| Market cap | $9.20B | $9.70B | -5% |
| P/E (TTM) | 22.6 | 62.5 | -64% |
| Forward P/E | 17.0 | 31.3 | -46% |
| Avg. volume | 2.58M | 1.88M | +37% |
Peer median across 8 companies: KYMR, RGEN, IBRX, TECH, IMVT, IOVA, HALO, KOD.
Valuation
- Market cap
- $9.20B
- P/E (TTM)
- 22.60
- Forward P/E
- 17.04
- Price / sales (latest FY)
- 4.40
- EPS (TTM)
- $1.97
- Shares outstanding
- 206.50M
Price and trading
- Previous close
- 44.79
- Open
- 44.44
- Day range
- 43.68 – 44.80
- 52-week range
- 32.53 – 57.82
- 52-week change
- -4.29%
- Beta
- —
- Volume
- 1.56M
- Average volume
- 2.58M
Dividends and events
- Annual dividend
- $0.363
- Dividend yield
- 0.82%
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 9.20B
- Pe
- 22.60
- Forward Pe
- 17.04
- Eps
- 1.97
- Dividend Yield
- 79.00%
- Dividend Rate
- 0.36
- Week52 High
- 57.82
- Week52 Low
- 32.53
- Avg Volume
- 2.58M
- Shares Outstanding
- 206.50M
- Ma50
- 43.35
- Ma200
- 42.45
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -22.99%
- Pct From52w Low
- 36.89%